DUALITAS THERAPEUTICS
HQ - South San Francisco
Summary
Dualitas Therapeutics is a biotechnology company developing bispecific antibody therapies for immunology and inflammation.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 48 M
Avg. Deal Size£ 48 M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite
